• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

欧盟中囊性纤维化的患病率。

The prevalence of cystic fibrosis in the European Union.

作者信息

Farrell Philip M

机构信息

The School of Medicine and Public Health, University of Wisconsin-Madison, 610 Walnut Street, 785 WARF, Madison, WI 53726-2397, United States.

出版信息

J Cyst Fibros. 2008 Sep;7(5):450-3. doi: 10.1016/j.jcf.2008.03.007. Epub 2008 Apr 28.

DOI:10.1016/j.jcf.2008.03.007
PMID:18442953
Abstract

This study combined a variety of methods to determine the prevalence of cystic fibrosis in the European Union. The results of literature reviews, surveys, and registry analyses revealed a mean prevalence of 0.737/10,000 in the 27 EU countries, which is similar to the value of 0.797 in the United States, and only one outlier, namely the Republic of Ireland at 2.98.

摘要

本研究结合了多种方法来确定欧盟国家囊性纤维化的患病率。文献综述、调查和登记分析结果显示，欧盟27个国家的平均患病率为0.737/10000，这与美国的0.797相近，只有一个异常值，即爱尔兰共和国，患病率为2.98。

相似文献

1
The prevalence of cystic fibrosis in the European Union.欧盟中囊性纤维化的患病率。
J Cyst Fibros. 2008 Sep;7(5):450-3. doi: 10.1016/j.jcf.2008.03.007. Epub 2008 Apr 28.
2
Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis.欧洲囊性纤维化人群的比较人口统计学：横断面数据库分析。
Lancet. 2010 Mar 20;375(9719):1007-13. doi: 10.1016/S0140-6736(09)62161-9.
3
Diagnosis of cystic fibrosis in the Republic of Ireland: epidemiology and costs.爱尔兰共和国囊性纤维化的诊断：流行病学与成本
Ir Med J. 2007 Sep;100(8):557-60.
4
CFTR H609R mutation in Ecuadorian patients with cystic fibrosis.厄瓜多尔囊性纤维化患者中的CFTR H609R突变
J Cyst Fibros. 2009 Jul;8(4):280-1. doi: 10.1016/j.jcf.2009.05.001. Epub 2009 May 19.
5
Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.囊性纤维化幼儿呼吸道病毒感染的患病率及影响：前瞻性队列研究
Pediatrics. 2008 Dec;122(6):1171-6. doi: 10.1542/peds.2007-3139.
6
A report on neurosurgical workforce in the countries of the EU and associated states. Task Force "Workforce Planning", UEMS Section of Neurosurgery.一份关于欧盟国家及相关国家神经外科劳动力的报告。“劳动力规划”特别工作组，欧洲医学专家联盟神经外科分会。
Acta Neurochir (Wien). 2009 Jun;151(6):715-21. doi: 10.1007/s00701-009-0396-0. Epub 2009 May 27.
7
Prevalence and survival of patients with cystic fibrosis in Northern Ireland, 1961-1971.1961 - 1971年北爱尔兰囊性纤维化患者的患病率及生存率
Ulster Med J. 1983;52(2):153-6.
8
Defining output-based standards to achieve and maintain tuberculosis freedom in farmed deer, with reference to member states of the European Union.参照欧盟成员国，制定基于产出的标准以实现并维持养殖鹿群无结核病状态。
Prev Vet Med. 2009 Aug 1;90(3-4):254-67. doi: 10.1016/j.prevetmed.2009.03.013. Epub 2009 May 23.
9
Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005.1995年至2005年美国囊性纤维化患者群体的临床特征趋势。
Pediatr Pulmonol. 2008 Aug;43(8):739-44. doi: 10.1002/ppul.20830.
10
Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients.斯堪的纳维亚囊性纤维化患者中囊性纤维化与乳糜泻的共病情况。
J Cyst Fibros. 2009 May;8(3):198-202. doi: 10.1016/j.jcf.2009.02.002. Epub 2009 Mar 19.

引用本文的文献

1
Special Issue "Research Advances on Cystic Fibrosis and CFTR Protein".特刊“囊性纤维化与CFTR蛋白的研究进展”
Int J Mol Sci. 2025 Jul 13;26(14):6708. doi: 10.3390/ijms26146708.
2
Impact of CFTR modulatory therapies on liver function and fibrosis indices in cystic fibrosis patients: a retrospective analysis from two Romanian medical centers.囊性纤维化跨膜传导调节因子（CFTR）调节疗法对囊性纤维化患者肝功能和纤维化指标的影响：来自罗马尼亚两个医学中心的回顾性分析
Med Pharm Rep. 2025 Jan;98(1):29-35. doi: 10.15386/mpr-2806. Epub 2025 Jan 31.
3
The Prevalence of Cystic Fibrosis—a Comparison of Patient Registry Data and Billing Data Within the German Statutory Health Insurance System.
囊性纤维化的患病率——德国法定医疗保险系统中患者登记数据与计费数据的比较
Dtsch Arztebl Int. 2024 Oct 18;121(21):712-713. doi: 10.3238/arztebl.m2024.0126.
4
Cystic fibrosis.囊性纤维化。
Nat Rev Dis Primers. 2024 Aug 8;10(1):53. doi: 10.1038/s41572-024-00538-6.
5
Cystic fibrosis patient characteristics and healthcare resource utilization in Finland using linked registries.利用关联登记系统对芬兰囊性纤维化患者特征及医疗资源利用情况的研究
Heliyon. 2024 Jun 22;10(13):e33439. doi: 10.1016/j.heliyon.2024.e33439. eCollection 2024 Jul 15.
6
One year effect of tezacaftor and ivacaftor on functional exercise capacity and muscle strength in people with cystic fibrosis.泰扎卡夫特和依伐卡托对囊性纤维化患者功能运动能力和肌肉力量的一年疗效。
Heliyon. 2024 Feb 20;10(5):e26729. doi: 10.1016/j.heliyon.2024.e26729. eCollection 2024 Mar 15.
7
Computational analysis of long-range allosteric communications in CFTR.CFTR 长程别构通讯的计算分析。
Elife. 2023 Dec 18;12:RP88659. doi: 10.7554/eLife.88659.
8
Lessons from across the pond: Student perspectives on the Internal Medicine clerkship experience at an Irish and Canadian medical school.来自大洋彼岸的经验教训：爱尔兰和加拿大医学院校学生对内科实习经历的看法。
MedEdPublish (2016). 2020 Jan 15;9:16. doi: 10.15694/mep.2020.000016.1. eCollection 2020.
9
as an organism model for studying cystic fibrosis and its major associated microbial infections.作为研究囊性纤维化及其主要相关微生物感染的一种机体模型。
Infect Immun. 2023 Nov 16;91(11):e0024023. doi: 10.1128/iai.00240-23. Epub 2023 Oct 17.
10
Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5.创新策略治疗囊性纤维化中的突变 CFTR：E3 连接酶 RNF5 的噻二唑抑制剂的设计与合成。
J Med Chem. 2023 Jul 27;66(14):9797-9822. doi: 10.1021/acs.jmedchem.3c00608. Epub 2023 Jul 13.